Latest Breaking News On - Thalassemia thalassaemia - Page 1 : comparemela.com

Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year.

United statesDrug administrationVertex pharmaceuticalGenomics genomic medicineBeta thalassemiaClustered regularly interspaced short palindromic repeatsCrispr cas9Thalassemia thalassaemiaBiologic therapyGene therapyTransplantation of stem cellsRansplantation of hematopoietic stem cellsHematopoietic stem cell transplantStem cell transplantationStem cell therapy